Kezar Life Sciences
77 hedge funds and large institutions have $123M invested in Kezar Life Sciences in 2020 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 29 increasing their positions, 26 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
1% less funds holding
Funds holding: 78 → 77 (-1)
93% less call options, than puts
Call options by funds: $5K | Put options by funds: $70K
Holders
77
Holding in Top 10
1
Calls
$5K
Puts
$70K
Top Buyers
| 1 | +$4.46M | |
| 2 | +$2.74M | |
| 3 | +$1.44M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.26M |
| 5 |
Wells Fargo
San Francisco,
California
|
+$447K |
Top Sellers
| 1 | -$4.51M | |
| 2 | -$2.27M | |
| 3 | -$1.77M | |
| 4 |
CA
CHI Advisors
New York
|
-$583K |
| 5 |
Victory Capital Management
San Antonio,
Texas
|
-$445K |